Results 181 to 190 of about 42,572 (273)

Assessment of novel sonographic and biochemical tools for spontaneous preterm birth prediction in asymptomatic twin pregnancies

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 104, Issue 6, Page 1162-1171, June 2025.
Multiple pregnancy substantially contributes to preterm birth rate worldwide. Sonographic markers of preterm birth, such as cervical length measurement, have limited prediction accuracy. Combining sonographic mid‐trimester cervical length with uterocervical angle improves the prediction of spontaneous preterm birth in asymptomatic and uncomplicated ...
Júlia Ponce   +12 more
wiley   +1 more source

A Pan‐Cancer Study of Tumour‐Associated Efferocytosis Core Genes and Preliminary Exploration of TIMD4 in Renal Cell Carcinoma

open access: yesJournal of Cellular and Molecular Medicine, Volume 29, Issue 12, June 2025.
ABSTRACT Efferocytosis plays a crucial role in maintaining the stability of the immune microenvironment. Increasing research indicates that efferocytosis core genes (ECGs) are not only widely expressed in immune cells, but also expressed at significant levels in tumour cells, impacting tumour progression.
Hongze Li   +5 more
wiley   +1 more source

Efficacy and safety of drospirenone as a progestin‐only pill in Japanese women: A phase III study

open access: yesJournal of Obstetrics and Gynaecology Research, Volume 51, Issue 6, June 2025.
Abstract Aim To evaluate the efficacy and safety of 4 mg of drospirenone (DRSP), a progestin‐only pill (POP), for contraception in Japanese women. Methods This was a multicenter, open‐label, single‐arm study. The dosing period of DRSP was 13 cycles, each lasting for 28 days. In one cycle, 4 mg of DRSP was administered orally once daily for the first 24 
Kunio Kitamura   +5 more
wiley   +1 more source

Proposal for a New Classification of Rare Cancers Adopting Updated Histological Tumor Types

open access: yesPathology International, Volume 75, Issue 6, Page 291-309, June 2025.
We propose a new rare cancer classification system using the updated International Classification of Diseases for Oncology 3.2 coding system and the World Health Organization Classification of Tumors 5th edition. This list could serve as a diagnostic classifier to reliably distinguish various rare cancers for clinical applications.
Ryoko Rikitake   +8 more
wiley   +1 more source

Beyond fluorodeoxyglucose: Molecular imaging of cancer in precision medicine

open access: yesCA: A Cancer Journal for Clinicians, Volume 75, Issue 3, Page 226-242, May/June 2025.
Abstract Cancer molecular imaging is the noninvasive visualization of a process unique to or altered in neoplasia, such as proliferation, glucose metabolism, and receptor expression, which is relevant to patient management. Several molecular imaging modalities are now available, including magnetic resonance, optical, and nuclear imaging.
Malik E. Juweid   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy